Exact Sciences' Cologuard Plus received FDA approval and expanded access for CRC screening in partnership with Humana and Mayo Clinic.
2 reports, 2 independent
Updated Aug 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Exact Sciences' Cologuard Plus received FDA approval and expanded access for CRC screening in partnership with Humana and Mayo Clinic.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Exact Sciences
American company in Madison, United States
- FDA
Related events
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.
- FDA approval supports commercial partner contracts for Vericel.
- Approval leads to procurement process initiation.
- FDA accepted Milestone's response to the Complete Response Letter (CRL).
Coverage
Newest first; wire copies grouped- Medical Device NetworkExact Sciences expands partnership with Humana to improve colorectal cancer screening Exact Sciences has expanded its collaboration with private insurer Humana to make the Cologuard Plus test availab
- Business WireExact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test Cologuard Plus™ Available In-Network August 2025 MADISON, Wis., July 31, 2025--(BUSINESS WIRE)--Exac